Incidence of Respiratory Syncytial Virus-Associated Lower Respiratory Tract Illness in Infants in Low- and Middle-Income Regions During the Coronavirus Disease 2019 Pandemic
© GSK 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America..
Background: Incidence data of respiratory syncytial virus-associated lower respiratory tract illness (RSV-LRTI) are sparse in low- and middle-income countries (LMICs). We estimated RSV-LRTI incidence rates (IRs) in infants in LMICs using World Health Organization case definitions.
Methods: This prospective cohort study, conducted in 10 LMICs from May 2019 to October 2021 (largely overlapping with the coronavirus disease 2019 [COVID-19] pandemic), followed infants born to women with low-risk pregnancies for 1 year from birth using active and passive surveillance to detect potential LRTIs, and quantitative reverse-transcription polymerase chain reaction on nasal swabs to detect RSV.
Results: Among 2094 infants, 32 (1.5%) experienced an RSV-LRTI (8 during their first 6 months of life, 24 thereafter). Seventeen (0.8%) infants had severe RSV-LRTI and 168 (8.0%) had all-cause LRTI. IRs (95% confidence intervals [CIs]) of first RSV-LRTI episode were 1.0 (.3-2.3), 0.8 (.3-1.5), and 1.6 (1.1-2.2) per 100 person-years for infants aged 0-2, 0-5, and 0-11 months, respectively. IRs (95% CIs) of the first all-cause LRTI episode were 10.7 (8.1-14.0), 11.7 (9.6-14.0), and 8.7 (7.5-10.2) per 100 person-years, respectively. IRs varied by country (RSV-LRTI: 0.0-8.3, all-cause LRTI: 0.0-49.6 per 100 person-years for 0- to 11-month-olds).
Conclusions: RSV-LRTI IRs in infants in this study were relatively low, likely due to reduced viral circulation caused by COVID-19-related nonpharmaceutical interventions.
Clinical Trials Registration: NCT03614676.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:10 |
---|---|
Enthalten in: |
Open forum infectious diseases - 10(2023), 12 vom: 13. Dez., Seite ofad553 |
Sprache: |
Englisch |
---|
Links: |
---|
Themen: |
Epidemiology |
---|
Anmerkungen: |
Date Revised 30.12.2023 published: Electronic-eCollection ClinicalTrials.gov: NCT03614676 Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.1093/ofid/ofad553 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM365797111 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM365797111 | ||
003 | DE-627 | ||
005 | 20240108140232.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1093/ofid/ofad553 |2 doi | |
028 | 5 | 2 | |a pubmed24n1243.xml |
035 | |a (DE-627)NLM365797111 | ||
035 | |a (NLM)38088983 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Fry, Samantha |e verfasserin |4 aut | |
245 | 1 | 0 | |a Incidence of Respiratory Syncytial Virus-Associated Lower Respiratory Tract Illness in Infants in Low- and Middle-Income Regions During the Coronavirus Disease 2019 Pandemic |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 30.12.2023 | ||
500 | |a published: Electronic-eCollection | ||
500 | |a ClinicalTrials.gov: NCT03614676 | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a © GSK 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. | ||
520 | |a Background: Incidence data of respiratory syncytial virus-associated lower respiratory tract illness (RSV-LRTI) are sparse in low- and middle-income countries (LMICs). We estimated RSV-LRTI incidence rates (IRs) in infants in LMICs using World Health Organization case definitions | ||
520 | |a Methods: This prospective cohort study, conducted in 10 LMICs from May 2019 to October 2021 (largely overlapping with the coronavirus disease 2019 [COVID-19] pandemic), followed infants born to women with low-risk pregnancies for 1 year from birth using active and passive surveillance to detect potential LRTIs, and quantitative reverse-transcription polymerase chain reaction on nasal swabs to detect RSV | ||
520 | |a Results: Among 2094 infants, 32 (1.5%) experienced an RSV-LRTI (8 during their first 6 months of life, 24 thereafter). Seventeen (0.8%) infants had severe RSV-LRTI and 168 (8.0%) had all-cause LRTI. IRs (95% confidence intervals [CIs]) of first RSV-LRTI episode were 1.0 (.3-2.3), 0.8 (.3-1.5), and 1.6 (1.1-2.2) per 100 person-years for infants aged 0-2, 0-5, and 0-11 months, respectively. IRs (95% CIs) of the first all-cause LRTI episode were 10.7 (8.1-14.0), 11.7 (9.6-14.0), and 8.7 (7.5-10.2) per 100 person-years, respectively. IRs varied by country (RSV-LRTI: 0.0-8.3, all-cause LRTI: 0.0-49.6 per 100 person-years for 0- to 11-month-olds) | ||
520 | |a Conclusions: RSV-LRTI IRs in infants in this study were relatively low, likely due to reduced viral circulation caused by COVID-19-related nonpharmaceutical interventions | ||
520 | |a Clinical Trials Registration: NCT03614676 | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a epidemiology | |
650 | 4 | |a incidence | |
650 | 4 | |a infants | |
650 | 4 | |a lower respiratory tract illness | |
650 | 4 | |a respiratory syncytial virus | |
700 | 1 | |a Chokephaibulkit, Kulkanya |e verfasserin |4 aut | |
700 | 1 | |a Pallem, Sridevi |e verfasserin |4 aut | |
700 | 1 | |a Henry, Ouzama |e verfasserin |4 aut | |
700 | 1 | |a Pu, Yongjia |e verfasserin |4 aut | |
700 | 1 | |a Akawung, Agnes |e verfasserin |4 aut | |
700 | 1 | |a Kim, Joon Hyung |e verfasserin |4 aut | |
700 | 1 | |a Yanni, Emad |e verfasserin |4 aut | |
700 | 1 | |a Tullio, Antonella Nadia |e verfasserin |4 aut | |
700 | 1 | |a Aurpibul, Linda |e verfasserin |4 aut | |
700 | 1 | |a Lee, Christine Mui Fong |e verfasserin |4 aut | |
700 | 1 | |a Ceballos, Ana |e verfasserin |4 aut | |
700 | 1 | |a Zaman, Khalequ |e verfasserin |4 aut | |
700 | 1 | |a Abadía de Regalado, Ivonne |e verfasserin |4 aut | |
700 | 1 | |a Ahmed, Khatija |e verfasserin |4 aut | |
700 | 1 | |a Arias Fernandez, Diana Andrea |e verfasserin |4 aut | |
700 | 1 | |a Taher, Sri Wahyu |e verfasserin |4 aut | |
700 | 1 | |a Caccavo, Juliana |e verfasserin |4 aut | |
700 | 1 | |a Coutinho, Conrado Milani |e verfasserin |4 aut | |
700 | 1 | |a D'Andrea Nores, Ulises |e verfasserin |4 aut | |
700 | 1 | |a De León, Tirza |e verfasserin |4 aut | |
700 | 1 | |a D'Silva, Emily Christine |e verfasserin |4 aut | |
700 | 1 | |a De Bernardi, Mara |e verfasserin |4 aut | |
700 | 1 | |a Dieser, Pablo |e verfasserin |4 aut | |
700 | 1 | |a Falaschi, Andrea |e verfasserin |4 aut | |
700 | 1 | |a Flores Acosta, Clara Del Carmen |e verfasserin |4 aut | |
700 | 1 | |a Gentile, Angela |e verfasserin |4 aut | |
700 | 1 | |a Teo, Ik Hui |e verfasserin |4 aut | |
700 | 1 | |a Kotze, Sheena |e verfasserin |4 aut | |
700 | 1 | |a López-Medina, Eduardo |e verfasserin |4 aut | |
700 | 1 | |a Luca, Ruben |e verfasserin |4 aut | |
700 | 1 | |a Lucion, Maria Florencia |e verfasserin |4 aut | |
700 | 1 | |a Mantaring, Jacinto Blas Iii V |e verfasserin |4 aut | |
700 | 1 | |a Marín, Bladimir |e verfasserin |4 aut | |
700 | 1 | |a Moelo, Malahleha |e verfasserin |4 aut | |
700 | 1 | |a Mussi-Pinhata, Marisa Márcia |e verfasserin |4 aut | |
700 | 1 | |a Pinto, Jorge |e verfasserin |4 aut | |
700 | 1 | |a Puthanakit, Thanyawee |e verfasserin |4 aut | |
700 | 1 | |a Reyes, Osvaldo |e verfasserin |4 aut | |
700 | 1 | |a Roa, Maria Fernanda |e verfasserin |4 aut | |
700 | 1 | |a Rodriguez Brieschke, María Teresa |e verfasserin |4 aut | |
700 | 1 | |a Rodriguez, Camilo Enrique |e verfasserin |4 aut | |
700 | 1 | |a Rodriguez Niño, Juan Nicolas |e verfasserin |4 aut | |
700 | 1 | |a Schwarzbold, Alexandre Vargas |e verfasserin |4 aut | |
700 | 1 | |a Sierra Garcia, Alexandra |e verfasserin |4 aut | |
700 | 1 | |a Sivapatham, Lavitha |e verfasserin |4 aut | |
700 | 1 | |a Soon, Ruey |e verfasserin |4 aut | |
700 | 1 | |a Tinoco, Juan Carlos |e verfasserin |4 aut | |
700 | 1 | |a Velásquez Penagos, Jesús Arnulfo |e verfasserin |4 aut | |
700 | 1 | |a Dos Santos, Gaël |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Open forum infectious diseases |d 2014 |g 10(2023), 12 vom: 13. Dez., Seite ofad553 |w (DE-627)NLM243576811 |x 2328-8957 |7 nnns |
773 | 1 | 8 | |g volume:10 |g year:2023 |g number:12 |g day:13 |g month:12 |g pages:ofad553 |
856 | 4 | 0 | |u http://dx.doi.org/10.1093/ofid/ofad553 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 10 |j 2023 |e 12 |b 13 |c 12 |h ofad553 |